{
    "nct_id": "NCT05212714",
    "official_title": "Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) to Reduce Post Traumatic Stress Disorder (PTSD) Symptoms in World Trade Center (WTC) Responders",
    "inclusion_criteria": "* being a Queens WTCHP responder who agreed to be contacted to participate in research\n* having PTSD as per DSM criteria indicated by the GRDC\n* having elevated PTSD symptoms, indicated by a PCL-S93 score > 44 during an annual monitoring visit between 2018-2020\n* having a score of 33 or greater on the PCL-594 delivered during the initial phone screen to determine current symptomatology\n* meeting diagnostic indication of PTSD using a Clinician-Administered PTSD Scale (CAPS), which is a clinical interview assessment.95\n\nExclusion criteria:\n\n* being physically/mentally unable to consent and participate\n* inability to speak, read, or write in English,\n* exhibiting any current psychotic or manic symptoms, active substance dependence, or current suicidal or homicidal intent/plan, as per the standard MINI neuropsychological assessment.96\n* active disease involving the auricle or ear canal (e.g., otitis media, tinnitus, infection, perforated tympanic membrane, vestibular and/or balance, excessive cerumen production, skin irritation), unwilling to remove a piercing (e.g., daith or tragus), or use a device (e.g., hearing aid, cochlear implant) that would preclude daily use of the earpiece.\n* history of unilateral or bilateral vagotomy.\n* Current pregnancy (self-report)\n* previously implanted electrically active medical devices (e.g., cardiac pacemakers, automatic implantable cardioverter-defibrillators, VNS).\n* other major conditions, that in the judgment of the investigators/WTCHP medical staff, would make the participant unsuitable for inclusion or would interfere with the participant participating in or completing the study. these include:\n\n  * current treatment with psychotropic medication, including tricyclics, antipsychotics, mood stabilizers, bupropion, barbiturates, stimulants, antiepileptics, opioid medications.\n  * current diagnosis or history of any clinically significant cardiac, endocrinologic, pulmonary, neurologic, psychiatric, hepatic, renal, hematologic, neurologic, gastrointestinal, or immunologic.\n  * history of any of the following cardiovascular conditions: Moderate to severe congestive heart failure (New York Heart Association class III or IV); Recent (within past 6 months) cerebrovascular accident, myocardial infarction, coronary stenting; Uncontrolled hypertension as defined by a confirmed systolic blood pressure > 160 mmHg or diastolic blood pressure > 100 mmHg.\n  * history of or active seizure disorder.\n  * history of recurrent vasovagal syncope episodes.\n  * diagnosis of cancer (other than non-invasive skin cancer or carcinoma in-situ of the cervix) within the 5 years prior to study entry.\n  * history of concurrent illness that requires hospitalization within 30 days prior to study entry\n  * have hypertension/hypotension uncontrolled by medication\n  * participation in another investigational trial during the 30 days prior to study entry or during this project\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}